Anatara Lifesciences prepares for GaRP-IBS trial results as anti-obesity research gains momentum
Anatara Lifesciences Ltd has announced that its Phase II GaRP-IBS trial is nearing completion, with the final headline analysis scheduled for March 2025. The company, ... Read More
Dr. Reddy’s Laboratories launches DailyBloom IBS : India’s first integrated care plan for irritable bowel syndrome
Dr. Reddy's Laboratories Ltd., a globally recognized pharmaceutical company, has unveiled DailyBloom IBS, marking a significant advancement in the management of Irritable Bowel Syndrome (IBS) ... Read More
Alfasigma acquires IBS-C drug Zelnorm from Sloan Pharma
Alfasigma acquisition of Zelnorm : Alfasigma USA, a subsidiary of Italian pharmaceutical company Alfasigma, has acquired IBS-C drug Zelnorm (tegaserod), a prescription treatment for irritable ... Read More